Does the PRECISE-DAPT score predict mid-term all-cause mortality in patients with acute coronary syndrome across different antithrombotic treatment strategies?
The PRECISE-DAPT score (threshold ≥ 25) is a valid prognostic tool for predicting mid-term all-cause mortality in ACS patients, particularly those with STEMI, regardless of their discharge antithrombotic regimen.
The PRECISE-DAPT score may be used for predicting mid-term all-cause mortality in acute coronary syndrome, with the best predictive ability in STEMI. The standard threshold ≥ 25 maintain acceptable prognostic performance regardless of antithrombotic treatment strategy at discharge.
Bauer et al. (Wed,) studied this question.